Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

EGFR

EGFR (epidermal growth factor receptor) is the cell-surface receptor of its specific ligands, including epidermal growth factor and TGFα (transforming growth factor α) and is a receptor tyrosine kinase.

Items 31-40 of 69

Page
per page
  1. RG-14620
    C4766 RG-14620
    Summary: inhibitor of epidermal growth factor (EGF) receptor kinase
      ≤1 mg/mL
  2. AG-213
    C4770 AG-213
    Summary: inhibitor of epidermal growth factor (EGF) receptor kinase
      ≤10 mg/mL
  3. AG-183
    C4844 AG-183
    Summary: inhibitor of epidermal growth factor (EGF) receptor kinase
      ≤20 mg/mL
  4. AG-1557
    C5417 AG-1557
    Summary: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase
      ≤0.5 mg/mL
  5. Mutant EGFR inhibitor
    B1103 Mutant EGFR inhibitor
    Summary: Selective Mutated EGFR inhibitor
      Soluble in DMSO
  6. Icotinib
    B1496 Icotinib
    Summary: EGFR tyrosine kinase inhibitor
      insoluble in H2O; ≥129.6 mg/mL
  7. AZD-9291
    B1104 AZD-9291
     1 Citation
    Target: EGFR
    Summary: Mutated forms EGFR inhibitor
      ≥24.98 mg/mL
  8. AZD-9291 mesylate
    B1105 AZD-9291 mesylate
    Summary: third generation EGFRm inhibitor, oral and irreversible
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  9. HKI 357
    B5456 HKI 357
    Summary: irreversible inhibitor of ErbB2 (HER2) and EGFR
      Soluble in DMSO
  10. WZ3146
    A8881 WZ3146
    Summary: Mutant EGFR inhibitor, potent and irreversible
      ≥23.25 mg/mL

Items 31-40 of 69

Page
per page